Market closedNon-fractional

Tyra Biosciences/TYRA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Tyra Biosciences

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).

Ticker

TYRA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Carlsbad, United States

Employees

49
Website
tyra.bio

Tyra Biosciences Metrics

BasicAdvanced
$1B
Market cap
-
P/E ratio
-$1.67
EPS
1.08
Beta
-
Dividend rate
$1B
1.08
44.835
44.053
1.569
1.664
-16.66%
-23.63%
2.64
2.64
-14.16
34.25%
-38.28%

What the Analysts think about Tyra Biosciences

Analyst Ratings

Majority rating from 6 analysts.
Buy

Tyra Biosciences Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$18M
-20.61%
Profit margin
0.00%
NaN%

Tyra Biosciences Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 23.11%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.31
-$0.49
-$0.53
-$0.35
-
Expected
-$0.34
-$0.35
-$0.48
-$0.46
-$0.41
Surprise
-9.80%
38.94%
10.26%
-23.11%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Tyra Biosciences stock?

Tyra Biosciences (TYRA) has a market cap of $1B as of July 15, 2024.

What is the P/E ratio for Tyra Biosciences stock?

The price to earnings (P/E) ratio for Tyra Biosciences (TYRA) stock is 0 as of July 15, 2024.

Does Tyra Biosciences stock pay dividends?

No, Tyra Biosciences (TYRA) stock does not pay dividends to its shareholders as of July 15, 2024.

When is the next Tyra Biosciences dividend payment date?

Tyra Biosciences (TYRA) stock does not pay dividends to its shareholders.

What is the beta indicator for Tyra Biosciences?

Tyra Biosciences (TYRA) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Tyra Biosciences stock

Buy or sell Tyra Biosciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing